e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
THE POTENTIAL IMPACT OF ANAEMIA OF CHRONIC DISEASE IN COPD.
T. SIMILOWSKI, A. AGUSTI, W. MACNEE AND B. SCHONHOFER. EUR RESPIR J 2006; 27: 390-396.
Source:
Eur Respir J 2006; 27: 1076
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. SIMILOWSKI, A. AGUSTI, W. MACNEE AND B. SCHONHOFER. EUR RESPIR J 2006; 27: 390-396.. THE POTENTIAL IMPACT OF ANAEMIA OF CHRONIC DISEASE IN COPD.. Eur Respir J 2006; 27: 1076
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
IMPACT OF CHRONIC ANEMIA ON THE EVOLUTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION (COPDE)
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ACCORDING TO STRENGTH IN UPPER LIMBS
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE (CTD-ILD): RETROSPECTIVE MULTICENTRIC STUDY
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020
HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
IMPACT OF TELEMONITORING ON PATIENTS WITH ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
DIFFERENCES IN PSYCHOLOGICAL FACTORS BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020
SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019
ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
CYTOKINE RESPONSE AND CD14CD282 CELLS IN NON-SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept